*ST Longjin: Announcement on Proposed Renewal of Accounting Firms
*ST Longjin: Announcement of Resolutions of the 7th Meeting of the 6th Board of Directors
*ST Longjin: Announcement of Resolutions of the 6th Meeting of the 6th Board of Directors
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Response from China Audit Zhonghuan Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Kunming Longjin Pharmaceutical Co., Ltd.
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Notice of Serious Unusual Fluctuations in Stock Trading
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: 002750*ST Longjin Investor Relations Management Information 20240514
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
Kunming Longjin Pharmaceutical: Announcement on participating in the 2023 Investor Online Group Reception Day for Listed Companies in Yunnan
Kunming Longjin Pharmaceutical: Notice of abnormal fluctuations in stock trading
No Data